ESIKA

Product NDC
13537-153
11-digit product format
135370153
Labeler code
13537
Product ID
13537-153_065f261c-4cdf-4c98-abce-66668713b2f5
Type
HUMAN OTC DRUG
Nonproprietary name
Avobenzone, Octisalate, Octocrylene, and Oxybenzone
Dosage form
LIQUID
Route
TOPICAL
Labeler
Ventura Corporation, Ltd.
Application
part352
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2012-01-24
Marketing end
0000-00-00
Substance
AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE
Active strength
0 g/mL; g/mL; g/mL; g/mL
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct13537-153DDiscontinued by firm2026-10-05
excluded packagepackage13537-15313537-153-01DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage13537-153-01DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage13537-153-01DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductIInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage13537-153-01IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductIInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage13537-153-01IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductIInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage13537-153-01IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductIInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage13537-153-01IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductIInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage13537-153-01IInactivated by FDA302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductIInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage13537-153-01IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductIInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage13537-153-01IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductIInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage13537-153-01IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductIInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage13537-153-01IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductIInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage13537-153-01IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproductIInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage13537-153-01IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproductIInactivated by FDA834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage13537-153-01IInactivated by FDA834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproductIInactivated by FDA1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage13537-153-01IInactivated by FDA1332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductIInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage13537-153-01IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproductIInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage13537-153-01IInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductIInactivated by FDAbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage13537-153-01IInactivated by FDAbd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproductIInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage13537-153-01IInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproductIInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage13537-153-01IInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproductIInactivated by FDA9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage13537-153-01IInactivated by FDA9bebd1f3094a…5416666fcb17…
2019-12-08 06:16 UTC · source 2019-12-05excluded productproductIInactivated by FDA110d247fa046…a55b01930146…
2019-12-08 06:16 UTC · source 2019-12-05excluded packagepackage13537-153-01IInactivated by FDA110d247fa046…a55b01930146…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
13537-153-012025-04-30C16284748780-197449f38-cc83-f6ea-e053-dbdaa90aa703ēsika Perfect sun
13537-153-012019-11-13C16284748780-197449f38-cc83-f6ea-e053-dbdaa90aa703ēsika Perfect sun

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
AvobenzoneACTIVE INGREDIENTG63QQF2NOXESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
OctisalateACTIVE INGREDIENT4X49Y0596WESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
OctocryleneACTIVE INGREDIENT5A68WGF6WMESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
OxybenzoneACTIVE INGREDIENT95OOS7VE0YESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
AvobenzoneACTIVE MOIETYG63QQF2NOXESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
OctisalateACTIVE MOIETY4X49Y0596WESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
OctocryleneACTIVE MOIETY5A68WGF6WMESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
OxybenzoneACTIVE MOIETY95OOS7VE0YESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
alkyl (c12-15) benzoateINACTIVE INGREDIENTA9EJ3J61HQESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
aloe vera leafINACTIVE INGREDIENTZY81Z83H0XESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
alpha-tocopherol acetateINACTIVE INGREDIENT9E8X80D2L0ESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
cyclomethicone 5INACTIVE INGREDIENT0THT5PCI0RESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1
dimethiconeINACTIVE INGREDIENT92RU3N3Y1OESIKA PERFECT SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LIQUID [VENTURA CORPORATION, LTD.]1